LPCAT1 and colorectal adenocarcinoma: suggested that LPCAT1 in colorectal adenocarcinoma contributed to total choline metabolite accumulation via phosphatidylcholine remodeling, thereby altered the lipid profile and increased the malignancy (32), but whether this applies to PCa requires further investigations.